Direct Vasodilators, Cardiac Ionotropes/glycosides Flashcards
Nitrates drugs, MOA, Net effect
Drugs:
Nitroglycerin isosorbide dinitrate (IDSN) - IDSN + hydralazine in CHF in African Americans Isosorbide mononitrate (ISMN) - portal HTN, no first pass effect, better bioavailability, longer 1/2 life
MOA: NO activates guanylate Cyclase -> increase cGMP to promote SM relaxation/vasodilation
Relaxes all segments of vascular SM from large arteries through large veins -> preload reduction
Affects afterload and preload!!!!
Net effect: vasodilation of arteries and veins -> decrease BP
Reduced myocardial O2 demand -> relaxed vasc SM -> dilation of peripheral venous vessels -> decrease venous return to heart -> decrease preload
Decrease afterload -> decrease ventricular wall tension -> decrease SVR -> decrease systolic arterial pressure
Nitrates ADRS and Uses
Uses: angina - affect preload and afterload
HTN, CHF, MI, portal HTN
ADRs: hypotension, reflex tachycardia, increased intracranial pressure
tolerance, headache, flushing, rash, dizziness, sweating, hypotension
Hypoxia/cyanosis: methylhemoglobinemia
No + OxyHb = MethHb
Strong affinity for O2
PDE-5 Inhibitors
Drugs: “-fil” slidenafil, taldalofil (BPH+ED), vardenafil, Avanafil
MOA: inhibit breakdown of cGMP -> more cGMP.
Physiologically - break down cGMP = flaccid
Net effect: relaxation, vasodilation
Uses: pulmonary arterial HTN, BPH, ED
ADRs: hypotension
Direct vasodilator
Minoxidil Hydralazine Nitroprusside Alpha 1 blockers CCDs
Minoxidil
Direct vasodilator - more potent then hydralazine
MUST combine with beta blocker and loop diuretic
MOA: vasodilation
Net effect: reduced peripheral resistance, decrease BP
Uses: servers drug resistant HTN
ADRs: peripheral edema
fluid retention, reflex tachycardia, hypotension, hypertrichosis (excessive hair growth)
Hydralazine
Direct vasodilator
MOA: vasodilation of arterial SM -> decrease BP and vascular resistance
Potent reflex SANS activation - reflex tachycardia
Net effect: relaxation of arterial smooth muscle
USes:
HTN
HF - in combo with IDSN (BiDil) in AA - last resort
HR in patients who cannot take ACE/ARBs
ADRs: peripheral edema, fluid retention, reflex tachycardia
Nitroprusside (IV)
Direct vasodilator
MOA: directly acts on arterial/venous Smooth muscle to liberate NO
Uses: HTN emergency, acute CHF
ADRs: hypotension, methemoglobenemia (cyanide toxicity)
Positive cardiac ionotrope
E/NE
Dobutamine
Isoproterenol
Dopamine
Milrinone
Inamrnione
Digoxin
PC ionotropes
Epi/NE
Dobutamine
Isoproterenol
Dopamine
MOA : increase myocardial contractibility
Net effect: Increase HR
Uses: shock, hypotension emergency
ADRs: HTN
PC ionotropes
Milrinone
Inamrinone
Inamrinone - better
MOA: PDE-3 inhibitors
Inhibits breakdown of cAMP -> positive ionotrope
Net effect: Increase HR
Uses: short term IV treatment of patients with acute decompensated HR, not used in chronic HF
ADRs: Ventricular arrythmia Hepatoxicity Thrombocytopenia Headache Hypokalemia (K) Tremor
PC ionotropes
Digoxin
MOA: reversible inhibitor of Na/K Atpase in myocardial cells
Competitively binds K binding site -> increase intracellular Na
Net effect: more intracellular Na = more intracellular Ca -> more contraction
Uses: CHF, rate control afib
ADRs: Hyperkalemia AV block Arrythmia Xanthopsia -> yellow tinted visions
Pt on Lisinopril ( inc K) -> digoxin less effect because more completion for K binding site
Pt on Hydrochlorathiazide (more Ca) give digoxin = more Ca on outside and want to bring Ca into heart -> greater effect of digoxin!